© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
The Role of the Pharmacist With Cholesterol Management: Focusing on New Guidelines and PCSK9 Inhibitors
Pharmacy Times, August 2019 Back to School, Volume 85, Issue 8
Continuing education for managing cholesterol with PCSK9 inhibitors.
Faculty
Joseph J. Saseen, PharmD, BCPS, BCACP, CLS, Professor and Vice Chair, Department of Clinical Pharmacy; Professor, Department of Family Medicine; University of Colorado Anschutz Medical Campus, Aurora Colorado
Educational Objectives
At the completion of this activity, the participant will be able to:
- Examine the pathophysiology, complications, and burden associated with hypercholesterolemia
- Identify updates to guidelines and the appropriate role of PCSK9 inhibitors in the management of hypercholesterolemia
- Explore various ways that pharmacists can make an impact and provide education for patients with hypercholesteremia to optimize outcomes
Target Audience: Pharmacists
Activity Type: Application
Release Date: August 12, 2019
Expiration Date: August 12, 2020
Estimated Time to Complete Activity: 2.0 hours
Fee: This lesson is offered for free at www.pharmacytimes.org